The House of Representatives has started an impeachment inquiry into President Trump. What does that mean for investors? First and foremost, I am politically agnostic. My sole job is to help investors achieve high risk-adjusted returns. This column is neither about politics nor about the merits of the impeachment inquiry.
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Today is the last day to save $2,605. Character of the market is changing. What worked in the last nine years is not likely to work in the future and may produce losses. The time to fine tune your skills for the future is now. Act now to register. Technology
President Trump’s economic adviser, Gary Cohn, said that starting this week the administration expects to launch a tax campaign that will lead to major legislation by the end of 2017. That would have major implications for investors, and you should consider trying to get ahead of it. To be prepared
In my 30-plus years in the markets, I can safely say that most popular analysis methods do not work well. Still, I can attest that a combination of forward-looking macro analysis combined with a review of earnings projections works most of the time. In plain English: Look for change. New
This post was just published on ZYX Buy Change Alert. In our divided country there are very few things on which Republicans and Democrats, liberals and conservatives agree. One of those very few things is that drug prices are too high. It makes no sense for Americans to often pay ten times
Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan keeps the basic framework of Obamacare. No wonder some are calling it “Obamacare Lite.”
This post was just published on ZYX Buy Change Alert. On February 1st we issued a call to take profits on MNTA. Depending upon how you traded, your profits would have been 74%. We got out at the top. Now the stock has fallen providing an opportunity to enter again. The buy
Donald Trump is starting his first full week as U.S. president. Bearish investors have been out in full force, proclaiming, with high confidence, that it’s time to sell stocks. At the same time, bullish gurus are saying just the opposite. So who’s right? Let’s explore the answer. First, we need
Donald Trump knocked yet another industry in his press conference Wednesday, but this time it wasn’t manufacturers or car makers. It was health care. And shares of U.S. pharmaceutical companies promptly fell, dropping by an average range of about 3% to 5%. “We’ve got to get our drug industry back,”